Evidence map›Paper›PMID 33071780›Full record

ArticleFrontiers in pharmacology2020

Slow-Release H

Chengcheng Zhao, Nannan Yu, Wenqun Li, Hualin Cai, Mouze Liu, Yanjie Hu, Yiping Liu, Mimi Tang

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in pharmacology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. HFrontiers in cell and developmental biology · 2026
    Review
  2. Review
  3. Sulfide regulation and catabolism in health and disease.Signal transduction and targeted therapy · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Chengcheng ZhaoDepartment of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha, China.
Nannan YuDepartment of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha, China.
Wenqun LiDepartment of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha, China.
Hualin CaiDepartment of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha, China.
Mouze LiuDepartment of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha, China.
Yanjie HuDepartment of Stomatology, Suiyang County People's Hospital, Zunyi, China.
Yiping LiuDepartment of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha, China.
Mimi TangDepartment of Pharmacy, Xiangya Hospital, Central South University, Changsha, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

"Lipotoxicity" induced by free fatty acids (FAs) plays a central role in the pathogenesis of many metabolic diseases, with few treatment options available today. Hydrogen sulfide (H

Indexed as

fatty acid β-oxidationhydrogen sulfidelipotoxicityliver injuriesoleic acidpalmitic acid

Identifiers

PMID33071780
PMCPMC7538629

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.